HS201-PDT had significant antitumor effects on BT474M1 (luminal B, ER+, HER2+) and the human patient derived BC xenograft, HCI-013 EI (invasive lobular, ER+, HER2−) (Fig. 8a, b). The gene discussed is ERBB2; the disease is breast cancer.